Skip to main content

Table 1 Primer sequences

From: NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

Gene-exon-segment

Application

Forward primer

Reverse primer

Product size/bp

TA/°C

Notch1- 26-a

PCR/SSCA

AGCCCCCTGTACGACCAGTA

CTTGCGCAGCTCCTCCTC

283

63.5

Notch1- 26-b

PCR/SSCA

ACACGGCCAGCAGATGAT

GAGAGTTGCGGGGATTGAC

231

57.1

Notch1- 27

PCR/SSCA

GTGGCGTCATGGGCCTCA

TAGCAACTGGCACAAACAGC

342

63.2

Notch1- 34a

PCR/SSCA

AACCACCTGCCTGGGATG

CGCATTGACCATTCAAACTG

232

57.1

Notch1- 34b

PCR/SSCA

GGGCCCTGAATTTCACTGT

AGGCCCTGGTAGCTCATCAT

229

60

Notch1- 34c

PCR/SSCA

GCTGCACAGTAGCCTTGCT

CTGAGCTCACGCCAAGGT

224

58

Notch1- 34d

PCR/SSCA

ACATCCAGCAGCAGCAAAG

GTGGGACCAGCGAGGATG

222

58

Notch1- 34e

PCR/SSCA

CACTATTCTGCCCCAGGAGA

CAGTCGGAGACGTTGGAATG

234

58

Notch1- 34f

PCR/SSCA

ACAGCTACTCCTCGCCTGTG

AAGGCTTGGGAAAGGAAGC

248

58

Notch1-6

PCR/SSCA

GCAGCTGCCCGGGGCCGACA

TCAGGCCTGGCCCATGTGA

330

62

Notch1-7

PCR/SSCA

ATGCCTGGCCAGGGGCCGT

TCGACTTCTCATCGGTTCT

273

58

Notch1-8

PCR/SSCA

CCGATGGGGGTGGTGTGCAGT

TGCCCAGCCTCGACTCGGTT

331

63

Notch1-11

PCR/SSCA

AGTCCTAAGTCTTCCTGTGCC

AGGCCCGCCCTGCCCACT

325

65

Notch1-12

PCR/SSCA

AGGACTGACCGACACGTG

TCTGAGCACAGTGCAGTCA

183

53

Notch1-13

PCR/SSCA

TGGGCGCTGGGCCTCGGA

ACTGATGTGTCCCCATGA

268

54

Gene-exon-segment

Application

Forward primer

Reverse primer

Product size/bp

T A /°C

Notch2- 26-1

PCR/SSCA

TTCTCTGCTTCCCCTTACCT

TTAATGCGCAGGTTGGTGT

250

54.1

Notch2- 26-2

PCR/SSCA

TGGTATTGATGCCACCTGAA

GCCTTGAAGTTCAGAAACCAA

240

54.1

Notch2- 27

PCR/SSCA

TACCCCCATCTCTCCTCCTC

AATTGTTCCCCCAATTGACA

250

55.2

Notch2- 34-1

PCR/SSCA

TCCCCTGTTGATTCCCTAGA

CACAATGTGGTGGTGGGATA

249

55.2

Notch2- 34-2

PCR/SSCA

GCACTGTGCTTCCCTCAGT

CTGCCTTTAGGGATGAGCTG

298

55.2

Notch2- 34-3

PCR/SSCA

ACCCATCCTGGCATAGCTC

TAGGCTGGGAGAATGGTCTG

287

55.2

Notch2- 34-4

PCR/SSCA

TTTGCCCAGTGTGGCTTT

GGTGATGAACTTGACCACTG

249

57.1

Notch2- 34-5

PCR/SSCA

ACACCCAGTCACAGTGGTCA

TGTCTCTACACTGGAGGTGGAC

242

61.6